Form Bio and Ginkgo Bioworks Unite to Revolutionize AAV Gene Therapy Development

Form Bio and Ginkgo Bioworks have forged a strategic partnership to offer an integrated solution for AAV gene therapy design and development. By leveraging Ginkgo's robust platform for cell programming and biosecurity alongside Form's sophisticated computational life sciences solutions, including characterization, simulation, and AI-driven construct design optimization, we are delivering a holistic approach to streamline the gene therapy development process. This collaboration aims to empower gene therapy developers with end-to-end capabilities, enabling them to optimize their products efficiently, reduce time-to-clinic, conserve capital, and ultimately strive for safer, more effective, and scalable outcomes in gene therapy research and development.